Resources
For the latest in nextgen biomed, sign up for our monthly newsletter to be among the first to receive exclusive insights, in-depth market analyses, and expert articles directly to your inbox

See how top pharma players are addressing impure, unstable, and off-target oligos

Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
.png)
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River

Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics

Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological

Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics

Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.

Regulatory
FDA Fast Track ADC for Patients with Triple Negative Breast Cancer
The fast track designation means that the clinical development and regulatory milestones of the drug candidate are likely to progress much faster.

Gene Therapy Development
Reshaping Genome Editing: Doudna & Charpentier, the Founders of CRISPR/Cas9 and Their Legacy
In 2020 Jennifer Doudna & Emmanuelle Charpentier were awarded the Nobel Prize in Chemistry for discovering the revolutionary gene-editing tool CRISPR/Cas9. This article shines a spotlight on their remarkable achievements and addresses current applications and future opportunities for CRISPR/Cas9.

Immunotherapy (Non-Oncology)
Scientists Develop First Mouse Model with Complete & Functional Human Immune System
The breakthrough in mouse models will allow researchers to study the human immune system in far greater detail at a far greater pace.

NextGen Therapeutics
GSK Buys CureVac's mRNA Vaccine Business Providing Welcome Cash Injection
CureVac will continue to build its R&D pipeline while allowing GSK to develop and commercialise a handful of its prophylactic mRNA vaccines.

Immuno-Oncology
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.

Bioanalysis
2002 Nobel Prize for Chemistry: Kurt Wüthrich, Using NMR to Determine the 3D Structure of Proteins
Kurt Wüthrich, joint winner of the 2002 Nobel Prize for Chemistry, contributed to the use of NMR to discover the 3D structure of proteins using sequential assignment and mathematical techniques.

Bioanalysis
Looking Back on the 2002 Nobel Prize for Chemistry: Mass Spectrometry for the Analysis of Proteins
2002's Nobel Prize for Chemistry recognised the translation of mass spectrometry to large molecules which has been instrumental in unlocking the proteome toward new therapies.

Cancer Vaccines
NHS Cancer Vaccine Launchpad to Give Thousands Access to Personalised Cancer Vaccines
NHS England aims to match up to 10,000 cancer patients to suitable personalised cancer vaccine clinical trials by 2030.

Antibody & Protein Engineering
Accelerating Biologics Discovery & Development Through Transformative Technologies & Overcoming Strategic Challenges
A concise report featuring insights from the prominent thought leaders of Biologics 2024
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things discovery